Potential Role of Anticancer Compounds Derived from Phytomedicines in Modulating the Signaling Pathways for Cancer Progression-A Review

Durga, L.; Gopathy, S.; Stafi, A.A.; Priya, K.S.; Rajagopal, P.

Texila International Journal of Public Health 13(1)

2025


ISSN/ISBN: 2520-3134
Accession: 096721680

Full-Text Article emailed within 1 workday
Payments are secure & encrypted
Powered by Stripe
Powered by PayPal

Summary
One of the most prevalent causes of death globally is cancer, which is a consequence of uncontrolled proliferation and division of cells in the body. The role of inflammation in tumour progression has been increasingly established. It also affects epigenetic changes that promote tumour induction and promotes all stages of carcinogenesis. Chronic inflammation may result in greater damage to DNA, interfere with DNA repair mechanisms, accelerate cellular division, and induce apoptosis, angiogenesis, and invasion of the tissue. A comprehensive knowledge of the cellular and molecular signaling mechanisms of tumor-endorsing inflammation is essential for the advancement of anti-cancer medications which concentrate on the interaction between malignancy formation and inflammatory mechanisms. Several inflammatory signalling pathways have been identified as regulating inflammation, including the NFκB signalling pathway, the JAK-STAT signalling pathway, the MAPK signalling, the PI3K/AKT/mTOR signalling and the Wnt signalling cascade. Several phytochemicals can treat cancer by altering these pathways. There are numerous classes of phytochemicals in herbal medicine that are being used therapeutically. Herbal medicine has shown to be especially beneficial for cancer patients, with many reporting a considerable increase in survivorship as a result of treatment. Cellular metabolism, tumour development, growth, proliferation, metastasis, and cytoskeletal reorganization are all regulated by aberrations in different cellular signalling pathways. The primary emphasis of the current review focuses on the phytochemical's capacity to combat cancer through modifying numerous cell signalling pathways.